{
    "clinical_study": {
        "@rank": "143124", 
        "arm_group": {
            "arm_group_label": "A", 
            "description": "All eligible CPCRA subjects"
        }, 
        "biospec_descr": {
            "textblock": "Any sample that can be used to test for M.tuberculosis"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "PRIMARY: To estimate the proportion of tuberculosis patients in the CPCRA who have\n      drug-resistant tuberculosis (TB) and to describe the patterns of drug resistance.\n\n      SECONDARY: To compare drug resistance data on the Mycobacterium tuberculosis isolates of\n      HIV-infected patients to those of HIV-uninfected patients who are being followed in the\n      CPCRA. To assess the relationship of resistance data with geographic, demographic, and HIV\n      and TB risk factor information.\n\n      Geographic areas and demographic subgroups affected by the TB epidemic appear to be\n      congruent and associated with the concurrent HIV epidemic. The total number of CPCRA\n      patients who will develop, or who have experienced, confirmed TB is unknown. It is critical\n      to determine the depth and breadth of the current problem of drug-resistant TB."
        }, 
        "brief_title": "A Registry of Tuberculosis Cases in the CPCRA", 
        "completion_date": {
            "#text": "June 1994", 
            "@type": "Actual"
        }, 
        "condition": [
            "HIV Infections", 
            "Tuberculosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Tuberculosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Geographic areas and demographic subgroups affected by the TB epidemic appear to be\n      congruent and associated with the concurrent HIV epidemic. The total number of CPCRA\n      patients who will develop, or who have experienced, confirmed TB is unknown. It is critical\n      to determine the depth and breadth of the current problem of drug-resistant TB.\n\n      For both retrospective and prospective components of the study, demographic, geographic, HIV\n      and TB risk factor information will be collected on CPCRA patients with confirmed pulmonary\n      or extrapulmonary TB. Mycobacterial culture results will be recorded. Retrospective data\n      will be collected on CPCRA patients with confirmed tuberculosis who have been diagnosed\n      since January 1992 until the time of site registration. Prospective data will be collected\n      on CPCRA patients with confirmed tuberculosis diagnosed during the period of 1 to 2 years\n      following site registration."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Patients must meet the following criteria:\n\n          -  CPCRA patients with confirmed pulmonary or extrapulmonary TB. Confirmed clinical TB\n             requires a positive culture for Mycobacterium tuberculosis.\n\n        NOTE:\n\n          -  There is no requirement that patients have HIV infection."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All eligible CPCRA subjects"
            }
        }, 
        "enrollment": {
            "#text": "1509", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000785", 
            "org_study_id": "CPCRA 017", 
            "secondary_id": "11568"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Tuberculosis", 
            "Mycobacterium tuberculosis", 
            "AIDS-Related Opportunistic Infections", 
            "Acquired Immunodeficiency Syndrome", 
            "Drug Resistance, Microbial"
        ], 
        "lastchanged_date": "September 28, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80204"
                    }, 
                    "name": "Denver CPCRA / Denver Public Hlth"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20422"
                    }, 
                    "name": "Veterans Administration Med Ctr / Regional AIDS Program"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60657"
                    }, 
                    "name": "AIDS Research Alliance - Chicago"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Louisiana Comm AIDS Rsch Prog / Tulane Univ Med"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48202"
                    }, 
                    "name": "Henry Ford Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201"
                    }, 
                    "name": "Comprehensive AIDS Alliance of Detroit"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07103"
                    }, 
                    "name": "North Jersey Community Research Initiative"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10456"
                    }, 
                    "name": "Bronx Lebanon Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brooklyn", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11201"
                    }, 
                    "name": "Addiction Research and Treatment Corp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10011"
                    }, 
                    "name": "Clinical Directors Network of Region II"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10037"
                    }, 
                    "name": "Harlem AIDS Treatment Group / Harlem Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97210"
                    }, 
                    "name": "Portland Veterans Adm Med Ctr / Rsch & Education Grp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23298"
                    }, 
                    "name": "Richmond AIDS Consortium"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Registry of Tuberculosis Cases in the CPCRA", 
        "overall_official": {
            "last_name": "Fred Gordin", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 1994", 
            "@type": "Actual"
        }, 
        "reference": {
            "PMID": "8912768", 
            "citation": "Gordin FM, Nelson ET, Matts JP, Cohn DL, Ernst J, Benator D, Besch CL, Crane LR, Sampson JH, Bragg PS, El-Sadr W. The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. Am J Respir Crit Care Med. 1996 Nov;154(5):1478-83."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000785"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "August 1992", 
        "study_design": "Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }, 
    "geocoordinates": {
        "AIDS Research Alliance - Chicago": "41.878 -87.63", 
        "Addiction Research and Treatment Corp": "40.653 -73.959", 
        "Bronx Lebanon Hosp Ctr": "40.85 -73.867", 
        "Clinical Directors Network of Region II": "40.714 -74.006", 
        "Comprehensive AIDS Alliance of Detroit": "42.331 -83.046", 
        "Denver CPCRA / Denver Public Hlth": "39.739 -104.985", 
        "Harlem AIDS Treatment Group / Harlem Hosp Ctr": "40.714 -74.006", 
        "Henry Ford Hosp": "42.331 -83.046", 
        "Louisiana Comm AIDS Rsch Prog / Tulane Univ Med": "29.951 -90.072", 
        "North Jersey Community Research Initiative": "40.736 -74.172", 
        "Portland Veterans Adm Med Ctr / Rsch & Education Grp": "45.523 -122.676", 
        "Richmond AIDS Consortium": "37.541 -77.436", 
        "Veterans Administration Med Ctr / Regional AIDS Program": "38.895 -77.036"
    }
}